A | 本周，新股市场热度不减。
周二（8月18日），频准激光在科创板上市，发行价为186.88元/股，为年内最高。
B | Unitree: Valuation rise reflects optimism Investors are showing a strong appetite for Unitree Robotics' initial public offering, reflecting growing optimism about China's ambition to turn its industrial chain strengths into commercially viable artificial intelligence applications in the physical world, market experts and investment banks said. Though still at an early stage of commercialization, China's embodied intelligence industry is gaining momentum in scaling up applications, first in business scenarios and later in consumer markets, creating a distinctive opportunity set for global investors, they said. The IPO of Unitree on Shanghai's STAR Market — the first A-share listing of a major producer of humanoid robots — has entered the subscription stage, with buoyant demand helping to lift its issue price and fundraising size above earlier expectations. Its issuing announcement showed that it had priced its IPO at 150.80 yuan ($22.35) per share, with expected proceeds amounting to 6.099 billion yuan, higher than the 4.202 billion yuan estimated in its earlier IPO filing at an implied price of about 104 yuan per share. Its IPO price represents a price-to-earnings ratio of 219.23 times, far surpassing the industry average of 38.56 times and giving it a market capitalization of about 60.99 billion yuan at the IPO price, the announcement said. The offering attracted a group of strategic investors, including the National Council for Social Security Fund, DeepSeek, as well as investment arms or affiliates of China National Petroleum Corp, China Southern Power Grid, China Telecom, Tencent and CITIC Securities. Notably, the social security fund has become Unitree's largest strategic investor, subscribing to 933,402 shares, or 2.31 percent of the offering, for around 141 million yuan. The move underscores long-term institutional capital's recognition of the humanoid robotics sector's prospects. Retail investors have also shown enthusiasm ahead of Unitree's online subscriptions that open on Monday, with posts wishing for successful allocations piling up on financial information platform Eastmoney's online stock forum for the company. Yang Shuning, executive director and partner at Wenzhi Capital, a Beijing-based private equity company focused on high-tech investments, said the keen demand and high valuation reflect investors' optimism about Unitree's commercialization prospects and its positioning in the embodied intelligence sector. "Given the scarcity premium enjoyed by leading players in tech sectors and the multibillion-dollar valuations seen among overseas humanoid robotics peers, Unitree's valuation is not without justification," he said. But Yang cautioned that Unitree's valuation is less about current earnings than about investors pricing in its future profitability. "If Unitree falls behind in scaling up commercialization, revenue growth weakens or investors start using a different valuation yardstick, valuations would come under pressure." Commercial promise Wang Xingxing, Unitree's founder and chairman, said on Friday that the company's pure humanoid robot shipments exceeded 5,500 units in 2025, the highest in the world. Unitree's rise has come as China's humanoid robotics sector takes the lead worldwide in terms of shipments, with its commercialization prospects becoming increasingly visible. Citing exhibition examples at the World Artificial Intelligence Conference in Shanghai, UBS said in a recent report that humanoid robots are "increasingly being evaluated as production tools rather than exhibition assets". Commercialization should first scale in structured business-to-business scenarios such as factories, logistics and smart pharmacies, while consumer use cases remain a longer-term prospect, the report said. Zhao Liang, a partner at Unique Capital, an investment institution focused on AI innovation, said that humanoid robots may integrate with specific application scenarios on a large scale in the next three to five years. "Given China's advantages in industrial supply chains and talent, the country's embodied intelligence industry chain may bring a surprise to the world," Zhao said. Unitree's listing, which took only 104 days to go from the application acceptance stage to registration approval, is expected to further boost financing, investment and development of China's embodied intelligence sector, experts said. Besides Unitree, another major Chinese humanoid manufacturer, AGIBOT, is seeking an IPO in Hong Kong. According to UBS, China's embodied AI sector saw a wave of IPO filings and strong primary market financing this year, with first-half funding going above 34.5 billion yuan. With a buoyant listing pipeline, China's embodied intelligence industry — and the broader physical AI sector — could offer global investors a distinct exposure to the next phase of AI development where physical-world applications become increasingly important, experts added. Goldman Sachs said in a report that while the US and North Asian tech companies hold a dominant position in sectors such as semiconductor and AI models, China's AI opportunity set seems better populated in power, infrastructure and physical AI, implying a potentially strong value proposition and diversification benefits to global investors. 
。上市首日开盘即报1100元/股，盘中最高触及1300元/股，中一签（500股）浮盈最高达55.66万元。
C | 紧接着，周三（8月19日）上市的宇树科技同样表现惊人，发行价150.80元/股，开盘价同样达到1100元/股，单签盈利超过47万元。两天连续出现千元开盘新股，在A股历史上较为罕见。 至此，A股年内单签盈利（按上市首日收盘价计算）超过10万元的“大肉签”新股已扩容至7只，分别是频准激光（单签盈利48.26万元）、宇树科技（单签盈利34.71万元）、联讯仪器（单签盈利35.86万元）、长进光子（单签盈利30.95万元）、臻宝科技（单签盈利27.02万元）、超纯应材（单签盈利21.85万元）、恒运昌（单签盈利13.96万元）。 根据目前的发行安排，下周（8月24日至8月30日）有4只新股申购。 从日程安排来看，周一（8月24日）可申购北交所新股华汇智能，周三（8月26日）可申购创业板新股洛轴股份和沪市主板新股天博智能，周五（8月28日）可申购创业板新股电科思仪。
D | 华汇智能申购代码为920289，发行价为17.71元/股，一签对应需缴款1771元，发行市盈率为14.99倍（行使超额配售选择权前）。网上申购时间为8月24日9:15至11:30及13:00至15:00。北交所新股申购无市值要求，采用全额资金缴款方式，需要开通北交所合格投资者权限才可参与申购。
E | 华汇智能是一家专业从事纳米砂磨机等智能装备及其关键部件的研发、设计、生产和销售的高新技术企业，其营业收入和毛利主要来源于研磨系统和纳米砂磨机的销售。 业绩方面，2023年、2024年、2025年，华汇智能营业收入分别为3.00亿元、4.27亿元、6.16亿元，归母净利润分别为0.46亿元、0.63亿元、0.80亿元。2026年1至6月，公司实现营业收入为3.57亿元，较上年同期实现小幅增长；净利润为0.54亿元，较上年同期增长10.53%。 招股说明书显示，报告期各期，华汇智能前五大客户合计销售收入占当期营业收入的比例分别为98.89%、96.90%和96.54%，其中公司向第一大客户湖南裕能的销售金额占当期营业收入的比例分别为49.19%、54.33%和82.82%，客户集中度高。若未来公司无法持续拓展客户以保持业务规模增长，则可能导致公司经营业绩无法持续增长。
洛轴股份：高端轴承领域龙头企业 周三（8月26日）可申购创业板新股洛轴股份。
F | 申购代码为301699，网上发行申购上限为14500股。 公开信息显示，洛轴股份主营轴承及相关零部件的研发、生产和销售，是中国轴承行业规模最大的综合性轴承制造企业之一，拥有轴承行业唯一国家重点实验室，在高端轴承领域研发与布局处于国内领先地位。根据中国轴承工业协会数据，2023年度至2024年度洛轴股份的轴承产品在中国国内轴承行业营业收入排名均为第4名。 业绩方面，2023年、2024年、2025年（下称报告期），洛轴股份的营业收入分别为44.41亿元、46.75亿元、60.34亿元，归母净利润分别为2.31亿元、2.51亿元、5.29亿元，2025年利润实现大幅增长。 值得注意的是，报告期各期末，洛轴股份资产负债率分别为82.19%、79.43%和79.57%，流动比率分别为0.99倍、1.01倍和1.07倍，偿债能力低于同行业可比公司平均水平。 天博智能本次公开发行股票数量为3000万股，网上发行申购上限为9500股，顶格申购需配沪市市值9.5万元。 公开信息显示，天博智能是行业内知名的汽车热管理系统零部件制造商，并拓展了汽车声学部件等业务。天博智能客户已覆盖国内大部分主机厂，2025年中国汽车销量前十位的车企集团均是公司的当期客户。根据中国汽车工业协会的证明，在其统计的范围内，2024年天博智能的汽车调温器和汽车温度传感器产品销量分别位列中国国内第1名和第4名。
G | 本次募集资金将投向智能热管理部件及系统制造、汽车热管理系统及核心元器件生产基地扩产改造、研发中心建设、信息化中心升级建设四大项目。
H | 业绩方面，2023年、2024年、2025年（下称报告期），天博智能的营业收入分别为12.70亿元、16.93亿元、19.61亿元，归母净利润分别为1.12亿元、3.23亿元、3.51亿元。2026年1至6月，公司实现营业收入9.45亿元，较上年同期小幅增长2.66%；归母净利润1.61亿元，较上年同期下降12.58%。 根据招股书披露数据，公司应收账款增长较快。报告期各期末，公司应收账款账面价值分别为4.41亿元、6.75亿元和5.69亿元，占流动资产的比例分别为29.43%、43.04%和31.34%，占比较高。 电科思仪：电子测量仪器龙头 电科思仪本次公开发行股票数量为10206.94万股，网上发行申购上限为12000股，顶格申购需配深市市值12万元。 电科思仪实际控制人为中国电子科技集团。公开资料显示，电科思仪主要从事电子测量仪器研发、制造和销售，是中国国内综合实力最强、收入规模最大的电子测量仪器研发制造企业，也是目前中国唯一能够在微波/毫米波、光电、通信和基础测量仪器领域全方位对标国际领先企业的电子测量仪器企业。 本次募集资金主要投向高端电子测量仪器生产线改造扩产、新一代移动通信测试研发与产业化、技术创新中心建设项目，同时补充流动资金。 业绩方面，2023年、2024年、2025年（下称报告期），电科思仪的营业收入分别为21.53亿元、20.52亿元、23.98亿元，归母净利润分别为1.90亿元、2.75亿元、4.38亿元。 招股说明书显示，报告期各期末，公司存货账面价值分别为11.70亿元、10.85亿元和10.68亿元，占当期总资产的比例分别为32.67%、28.84%和25.50%。公司存货余额规模较大且占比较高，高于同行业可比公司。（文章来源：中新经纬）。
Current article:http://u41.recuigoutoubaozukai.pics/list_m8z27/6xall6f.html
Published on:14:32:20
